SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-001524
Filing Date
2023-02-01
Accepted
2023-02-01 07:29:05
Documents
14
Period of Report
2023-01-27
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K grna-20230127.htm   iXBRL 8-K 66928
2 EX-99.1 grna-ex99_1.htm EX-99.1 35836
  Complete submission text file 0000950170-23-001524.txt   269742

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT grna-20230127.xsd EX-101.SCH 3461
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT grna-20230127_def.xml EX-101.DEF 13862
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT grna-20230127_pre.xml EX-101.PRE 13162
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT grna-20230127_lab.xml EX-101.LAB 18086
8 EXTRACTED XBRL INSTANCE DOCUMENT grna-20230127_htm.xml XML 6661
Mailing Address 200 BOSTON AVENUE SUITE 3100 MEDFORD MA 02155
Business Address 200 BOSTON AVENUE SUITE 3100 MEDFORD MA 02155 (617) 616-8188
GreenLight Biosciences Holdings, PBC (Filer) CIK: 0001822691 (see all company filings)

IRS No.: 851914700 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39894 | Film No.: 23574726
SIC: 2836 Biological Products, (No Diagnostic Substances)